2018-2023 Intravenous Fluid Bags Consumption Market Report

0
20

In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Intravenous Fluid Bags market for 2018-2023.

Intravenous solutions contain amino acids, dextrose, mineral salts, vitamins, and trace elements, and therefore cover the basic essential components (carbohydrates, proteins, fats, water, electrolytes, vitamins, and minerals) required to build tissue, for energy expenditure, and other physiological activities. A complete mixture of all vital nutrients is also available in multi-chamber bags, which are gaining immense popularity.
Intravenous Fluid Bags are widely used in hospitals, nursing homes and at-home healthcare, also other related health centers. Among which hospitals occupied almost half of total market share, at-home healthcare occupied about 18% market share, and developed countries contribute a lot in this field.
There are more changes as the calendar changes to next few years. Government compliance, new integrated strategies and incentive programs all figure to play a major role in this developing market, where change seems to be the only constant.
Over the next five years, LPI(LP Information) projects that Intravenous Fluid Bags will register a 3.7% CAGR in terms of revenue, reach US$ 3210 million by 2023, from US$ 2580 million in 2017.

This report presents a comprehensive overview, market shares, and growth opportunities of Intravenous Fluid Bags market by product type, application, key manufacturers and key regions.

 

To calculate the market size, LP Information considers value and volume generated from the sales of the following segments:

 

Segmentation by product type:
PVC Material
Non- PVC Material
Segmentation by application:
Home Health Care
Hospitals
Other Healthcare Centers

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report:
Baxter
B. Braun
Hospira (Pfizer)
SIPPEX
Amcor
Smiths Medical
Wipak
JW Life Science
Fresenius Kabi

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Intravenous Fluid Bags consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
To understand the structure of Intravenous Fluid Bags market by identifying its various subsegments.
Focuses on the key global Intravenous Fluid Bags manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Intravenous Fluid Bags with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Intravenous Fluid Bags submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

 

LEAVE A REPLY

Please enter your comment!
Please enter your name here